Conformis, Inc. (CFMS) |
| 2.27 0.01 (0.44%) 09-01 15:57 |
| Open: | 2.26 |
| High: | 2.27 |
| Low: | 2.25 |
| Volume: | 7,081 |
| Market Cap: | 18(M) |
| PE Ratio: | -0.4 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 7.25 |
| 52w Low: | 1.05 |
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Thu, 24 Apr 2025
CFMS Stock Price, News & Analysis | Conformis - Stock Titan
Fri, 22 Nov 2024
Laurent Souviron Net Worth (2026) - GuruFocus
Thu, 22 Jun 2023
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash - GlobeNewswire
Tue, 08 Nov 2022
Christofilis, Constantinos Net Worth (2026) - GuruFocus
Tue, 16 Aug 2022
Conformis achieves highest satisfaction rate in the industry for its transformative knee arthroplasty - Proactive financial news
Thu, 23 Dec 2021
Conformis Chief Legal Officer Brent Alldredge to Retire - citybiz
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |